Stand Up To Cancer (SU2C) is a groundbreaking initiative created to accelerate innovative cancer research that gets new therapies to patients quicker. Since its inception, SU2C has announced nine Food and Drug Administration (FDA) approvals for new cancer therapies supported by SU2C research. Major League Baseball and its 30 Clubs have donated more than $50 million to SU2C since the partnership was first formed in 2009. As a founding donor, MLB has conducted significant awareness-building efforts through public service announcements, in-stadium promotions and various fundraising events. Learn more about SU2C at StandUpToCancer.org/MLB.
If you've been diagnosed with cancer, a clinical trial may offer access to the latest and most promising science, while helping to light the path for future survivors. More »